This study is NOT currently recruiting participants.
Number
14-CC-0027
Sponsoring Institute
National Institutes of Health Clinical Center (CC)
Recruitment Detail
Type: Completed Study; data analyses ongoing Gender: Male & Female Min Age: 21 Years Max Age: 80 Years
Referral Letter Required
No
Population Exclusion(s)
Children;Non-English Speaking
Keywords
Exercise; Interstitial Lung Disease; Pulmonary Rehabilitation
Recruitment Keyword(s)
None
Condition(s)
Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis; Interstitial Pneumonitis; Desquamative Interstitial Pneumonia
Investigational Drug(s)
Investigational Device(s)
Intervention(s)
Other: Aerobic Exercise Training (AET) Other: Education
Supporting Site
NIH Clinical CenterGeorge Mason UniversityInova Fairfax Hospital
This study is a randomized controlled trial to determine the safety and efficacy of aerobic exercise for patients who have interstitial lung disease (ILD) uncomplicated by pulmonary hypertension. In an uncontrolled study, we observed more efficient cardiorespiratory function, increased physical work capacity, and improved health-related quality of life following aerobic exercise in this study population. Serious adverse events resulting from aerobic exercise training were not observed and our work to date has established plausibility for the efficacy of aerobic exercise training and its safety for patients with ILD.
--Back to Top--
INCLUSION CRITERIA: A diagnosis of interstitial lung disease, including idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonitis (NSIP), sarcoidosis, or other form of chronic lung fibrosis based on clinical context via clinic note from a pulmonologist. Individuals with ILD referred for pulmonary rehabilitation who are 21-80 years of age and live in the Washington metropolitan area. No episodes of fainting or significant chest pain for at least one month. No prior pulmonary rehabilitation received within the last 6 months and not currently in a maintenance program. Physically inactive (no participation in a structured exercise program as defined as more than 30 minutes of exercise 3 or more days a week within the last 6 months). EXCLUSION CRITERIA: Other medical conditions that would impair aerobic capacity or the ability to engage in physical activity, including other pulmonary, cardiovascular, neurological, musculoskeletal or metabolic conditions Other medical conditions that may pose a risk to exercise testing or training as determined by the investigators (for example, peripheral vascular disease) Diagnosis of pulmonary hypertension Inability to maintain a resting oxygen saturation greater than or equal to 90% SpO2, measured by pulse oximetry on supplemental oxygen Inability to complete a treadmill cardiopulmonary exercise test. Significant hepatic or renal dysfunction. Metastatic cancer with a life expectancy of less than one year. Active substance abuse. Severe psychiatric disease Antiretroviral therapy Pregnancy Ongoing tobacco use Acceptance onto a lung transplant waiting list Active participation in ILD drug trials Inability to read English
A diagnosis of interstitial lung disease, including idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonitis (NSIP), sarcoidosis, or other form of chronic lung fibrosis based on clinical context via clinic note from a pulmonologist.
Individuals with ILD referred for pulmonary rehabilitation who are 21-80 years of age and live in the Washington metropolitan area.
No episodes of fainting or significant chest pain for at least one month.
No prior pulmonary rehabilitation received within the last 6 months and not currently in a maintenance program.
Physically inactive (no participation in a structured exercise program as defined as more than 30 minutes of exercise 3 or more days a week within the last 6 months).
EXCLUSION CRITERIA:
Other medical conditions that would impair aerobic capacity or the ability to engage in physical activity, including other pulmonary, cardiovascular, neurological, musculoskeletal or metabolic conditions
Other medical conditions that may pose a risk to exercise testing or training as determined by the investigators (for example, peripheral vascular disease)
Diagnosis of pulmonary hypertension
Inability to maintain a resting oxygen saturation greater than or equal to 90% SpO2, measured by pulse oximetry on supplemental oxygen
Inability to complete a treadmill cardiopulmonary exercise test.
Significant hepatic or renal dysfunction.
Metastatic cancer with a life expectancy of less than one year.
Active substance abuse.
Severe psychiatric disease
Antiretroviral therapy
Pregnancy
Ongoing tobacco use
Acceptance onto a lung transplant waiting list
Active participation in ILD drug trials
Inability to read English
Principal Investigator
Referral Contact
For more information: